BioCentury
ARTICLE | Clinical News

SUBA-Itraconazole: Pivotal trial data

March 8, 2010 8:00 AM UTC

Preliminary data from a U.K. pivotal pharmacokinetic study showed that a half-dose of SUBA-Itraconazole was bioequivalent to Sporanox itraconazole from Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J...